DAPA-HF

Dr. John McMurray

Professor of Medical Cardiology,

University of Glasgow,

Glasgow, Scotland, UK

EMPEROR-Reduced

Dr. Milton Packer

Distinguished Scholar and Professor

of Medicine,

Baylor University Medical Center,

Dallas, TX , USA

VICTORIA

Dr. Paul Armstrong

Distinguished University Professor,

University of Alberta,

Founding Director,Canadian VIGOUR Centre,

Edmonton, AB, Canada

ARNIs in HFrEF and HFpEF

Dr. Scott Solomon

Professor of Medicine,

Harvard Medical School,

Boston, MA, USA

GALACTIC-HF

Dr. John Teerlink

Professor of Medicine,

University of California San Francisco,

San Francisco, CA, USA

AFFIRM-AHF

Dr. Piotr Ponikowski

Professor of Medical Sciences

and Vice-Rector,

Wroclaw Medical University,

Wrocław, Poland

So many drugs - do we have to choose?

Dr. Carolyn Lam

Professor of Cardiology,

Duke–National University of

Singapore Medical School,

Singapore

Ongoing trials on heart failure

Dr. John McMurray

Professor of Medical Cardiology,

University of Glasgow,

Glasgow, Scotland, UK

From FOURIER to ODYSSEY OUTCOMES

Dr. Ph. Gabriel Steg

Professor of Cardiology,

Université Paris - Diderot,

Paris, France;

Imperial College London,

London, England, UK

HPS-4/TIMI 65/ORION-4

Dr. David Preiss

Associate Professor of Population Health,

University of Oxford,

Oxford, England, UK

REDUCE-IT

Dr. Deepak Bhatt

Professor of Medicine,

Harvard Medical School,

Boston, MA, USA

ISCHEMIA

Dr. Judith Hochman

Harold Snyder Family Professor of Cardiology,

NYU Grossman School of Medicine,

New York, NY, USA

COMPASS

Dr. John Eikelboom

Professor of Medicine,

McMaster University,

Hamilton, ON, Canada

ISAR-REACT 5

Dr. Adnan Kastrati

Professor of Internal Medicine

Technische Universität München,

Munich, Germany

LoDoCo2

Dr. Arend Mosterd

Cardiologist,

Meander Medical Center,

Amersfoort, Netherlands

Converting atherosclerosis

trials into the practice

Dr. Erin Bohula May

Instructor in Medicine,

Harvard Medical School,

Boston, MA, USA

Ongoing trials on atherosclerosis

Dr. Deepak Bhatt

Professor of Medicine,

Harvard Medical School,

Boston, MA, USA

Insights from GLP-1RA trials

Dr. Tina Vilsbøll

Professor of Internal Medicine

University of Copenhagen,

Copenhagen, Denmark

VERTIS CV

Dr. Darren McGuire

Distinguished Teaching Professor of Medicine,

UT Southwestern Medical Center,

Dallas, TX, USA

Let’s talk stepwise vs combination

Dr. Subodh Verma

Professor of Surgery and

Pharmacology & Toxicology,

University of Toronto,

Canada Research Chair in

Cardiovascular Surgery,

Toronto, ON, Canada

Ongoing SGLT2i trials in

diabetes and beyond

Dr. Pardeep Jhund

Clinical Senior Lecturer

University of Glasgow,

Glasgow, Scotland, UK

Ongoing GLP-1RA trials in

diabetes and beyond

Dr. Mark Petrie

Professor of Cardiology,

University of Glasgow,

Glasgow, Scotland,UK

The heart-kidney interface

Dr. Faiez Zannad

Emeritus Professor of Therapeutics,

Université de Lorraine,

Grand Est, France

CREDENCE

Dr. Vlado Perkovic

Dean of Medicine and Scientia Professor,

University of New South Wales,

Sydney, NSW, Australia

DAPA-CKD

Dr. Hiddo Lambers Heerspink

Professor of Clinical Trials and

Personalized Medicine,

University Medical Centre Groningen,

Groningen, Netherlands

FIDELIO-DKD

Dr. Stefan Anker

Professor of (Tissue) Homeostasis in

Cardiology & Metabolism,

Charité Campus Virchow-Klinikum,

Berlin, Germany

Looping in the new therapies

Dr. Meg Jardine

Professor of Medicine,

University of Sydney,

NSW, Australia

Ongoing trials on kidney disease

Dr. Hiddo Lambers Heerspink

Professor of Clinical Trials and

Personalized Medicine,

University Medical Centre Groningen,

Groningen, Netherlands